U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07731542) titled 'Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial' on July 21.
Brief Summary: The VIVA trial is a 12-week, randomized, interventional study comparing vonoprazan monotherapy versus vonoprazan plus itopride combination therapy in adults with functional dyspepsia (FD). FD is a common digestive disorder causing upper stomach discomfort, fullness after meals, and early satiety.
The study aims to determine if adding itopride, a prokinetic that improves stomach emptying, to vonoprazan, a strong acid-suppressing drug, provides better symptom relief than vonoprazan alone. Participants will be randomly assigned to re...